Endarterectomy vs. Stenting in Asymptomatic Carotid Artery Stenosis

The comparative efficacy and safety of carotid stenting vs. endarterectomy in asymptomatic carotid stenosis patients remains controversial and, what is worse, consensus seems unlikely in the near future. Given the lack of definite evidence, several meta-analyzis and systematic reviews have been produced in an attempt to shed some light on this matter.

Enfermedad carotidea asintomática: ¿Endarterectomía o angioplastia?

This study included all controlled and randomized trials comparing both techniques in asymptomatic patients using a pre-specified protocol.

 

Five controlled studies met the inclusion criteria, adding up more than 3,000 patients.


Read also: New Strategies for the Femoropopliteal Artery”.


The pooled incidence of any periprocedural stroke (RR 1.84; CI 95%, 0.99–3.40), periprocedural nondisabling stroke (RR 1.95; CI 95%, 0.98 – 3.89) and any periprocedural stroke or death (RR 1.72; CI 95%, 0.95 – 3.11) show a tendency against stenting. This tendency was observed in periprocedural events, with no difference in stroke at long term (RR 1.24; CI 95%, 0.76 – 2.03) or with the composite of periprocedural stroke, death, MI or ipsilateral stroke at long term (RR 0.92; IC 95%, 0.70–1.21).

 

Conclusion

The best revascularization technique for patients with asymptomatic carotid stenosis continues to be a matter of debate, despite the higher incidence of periprocedural stroke against stenting seems to tilt the scales in favor of endarterectomy.

 

Editorial Comment

The estimated risk of ipsilateral stroke for asymptomatic patients with a ≥50% stenosis to the internal carotid artery is as low as 0.5 or 1% per year. Hence, in order to show the benefits of revascularization, if any, we would need long term follow up.


Read also: Diabetics’ Silent Ischemia Myth Busted”.


The best medical treatment should be prescribed to these patients, but randomized studies comparing stenting vs. endarterectomy were carried out mostly between 1980 and 2000. Without a shadow of a doubt, current medical treatments are highly superior to any medical treatment two decades old, which is why we should consider a third option to treat these patients, one that the original studies had not considered.

 

At present, there are two randomized studies in progress (SPACE-II y CREST-II) that will provide valuable data on the comparative safety and efficacy of the best medical treatment vs. stenting + the best medical treatment vs. endarterectomy + the best medical treatment.

 

Original title: Carotid Stenting Versus Endarterectomy for Asymptomatic Carotid Artery Stenosis. A Systematic Review and Meta-Analysis.

Reference: Paola Moresoli et al. Stroke. 2017 Aug;48(8):2150-2157.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...